Malignant mesothelioma: the antiproliferative effect of cytokine combinations on three human mesothelioma cell lines
- 1 July 1991
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 58 (3), 205-210
- https://doi.org/10.1016/0304-3835(91)90102-n
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Original article: Potentiation of cisplatin by alpha-Interferon in advanced non-small cell lung cancer (NSCLC): A phase II studyAnnals of Oncology, 1990
- Tumour necrosis factor: a cytokine with multiple biological activitiesBritish Journal of Cancer, 1990
- Intraperitoneal tumor growth and chemotherapy in a rat modelEuropean Journal of Cancer and Clinical Oncology, 1989
- Effect of Tumor Necrosis Factor and Interferon Gamma on Human Renal Carcinoma Cell Line GrowthJournal of Urology, 1989
- Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism.Journal of Clinical Oncology, 1988
- Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blastsBritish Journal of Cancer, 1987
- Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell linesInternational Journal of Cancer, 1986
- Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human cell linesEuropean Journal of Cancer and Clinical Oncology, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- In vitro systems for evaluation of combination chemotherapyPharmacology & Therapeutics, 1980